Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations

In the present study, simultaneous determination of antazoline hydrochloride (ANZ) and naphazoline hydrochloride (NFZ) in ophthalmic formulations by newly developed ultra-fast liquid chromatographic (UFLC) method was optimized. UFLC separation was performed with ACE Excel 2 C18-PFP column (2 μm, 2.1...

Full description

Bibliographic Details
Main Authors: Mahmood Ahmed, Amir Ali, Umar Farooq, Muhammad Makshoof Athar, Kashif Nadeem, Ghulam Murtaza
Format: Article
Language:English
Published: Slovenian Chemical Society 2017-06-01
Series:Acta Chimica Slovenica
Subjects:
Online Access:https://journals.matheo.si/index.php/ACSi/article/view/3166
_version_ 1819036573430185984
author Mahmood Ahmed
Amir Ali
Umar Farooq
Muhammad Makshoof Athar
Kashif Nadeem
Ghulam Murtaza
author_facet Mahmood Ahmed
Amir Ali
Umar Farooq
Muhammad Makshoof Athar
Kashif Nadeem
Ghulam Murtaza
author_sort Mahmood Ahmed
collection DOAJ
description In the present study, simultaneous determination of antazoline hydrochloride (ANZ) and naphazoline hydrochloride (NFZ) in ophthalmic formulations by newly developed ultra-fast liquid chromatographic (UFLC) method was optimized. UFLC separation was performed with ACE Excel 2 C18-PFP column (2 μm, 2.1 x 100 mm) with 0.6 mL/min flow rate of mobile phase which consisted of acetonitrile/phosphate buffer in the ratio of 60:40 (v/v) at 40 ˚C and pH adjusted to 3.0 with 0.5 % v/v triethylamine. The detection of ANZ and NFZ was performed at a wavelength of 285 nm and injection of samples was 1.0 µL. The runtime for analysis was 4.5 min and retention times of NFZ and ANZ were found to be 0.92 and 1.86 min, respectively. The calibration graph was linear for ANZ and NFZ with r2 greater than 0.998 while repeatability and reproducibility (expressed as RSD %) were lower than 1.28 % and 2.14 % respectively. Comparison of UFLC was done with HPLC, UFLC method had remarked advantages over HPLC as run time reduced by 3.4 fold and solvent consumption decreased 5 times. Moreover, detection limits determined by UFLC were 1.5 fold less than HPLC. Force degradation indicated the complete separation of analytes in the presence of degradation products provided the justification of method specificity. The proposed UFLC method was demonstrated to be simple and rapid for the determination of ANZ and NFZ in ophthalmic solutions providing recoveries in the range between 99.6 and 100.4 %.
first_indexed 2024-12-21T08:07:40Z
format Article
id doaj.art-462da75f7a84436e8748623c71214355
institution Directory Open Access Journal
issn 1318-0207
1580-3155
language English
last_indexed 2024-12-21T08:07:40Z
publishDate 2017-06-01
publisher Slovenian Chemical Society
record_format Article
series Acta Chimica Slovenica
spelling doaj.art-462da75f7a84436e8748623c712143552022-12-21T19:10:45ZengSlovenian Chemical SocietyActa Chimica Slovenica1318-02071580-31552017-06-0164233234110.17344/acsi.2017.3166459Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulationsMahmood Ahmed0Amir AliUmar FarooqMuhammad Makshoof AtharKashif NadeemGhulam MurtazaIOC-PUIn the present study, simultaneous determination of antazoline hydrochloride (ANZ) and naphazoline hydrochloride (NFZ) in ophthalmic formulations by newly developed ultra-fast liquid chromatographic (UFLC) method was optimized. UFLC separation was performed with ACE Excel 2 C18-PFP column (2 μm, 2.1 x 100 mm) with 0.6 mL/min flow rate of mobile phase which consisted of acetonitrile/phosphate buffer in the ratio of 60:40 (v/v) at 40 ˚C and pH adjusted to 3.0 with 0.5 % v/v triethylamine. The detection of ANZ and NFZ was performed at a wavelength of 285 nm and injection of samples was 1.0 µL. The runtime for analysis was 4.5 min and retention times of NFZ and ANZ were found to be 0.92 and 1.86 min, respectively. The calibration graph was linear for ANZ and NFZ with r2 greater than 0.998 while repeatability and reproducibility (expressed as RSD %) were lower than 1.28 % and 2.14 % respectively. Comparison of UFLC was done with HPLC, UFLC method had remarked advantages over HPLC as run time reduced by 3.4 fold and solvent consumption decreased 5 times. Moreover, detection limits determined by UFLC were 1.5 fold less than HPLC. Force degradation indicated the complete separation of analytes in the presence of degradation products provided the justification of method specificity. The proposed UFLC method was demonstrated to be simple and rapid for the determination of ANZ and NFZ in ophthalmic solutions providing recoveries in the range between 99.6 and 100.4 %.https://journals.matheo.si/index.php/ACSi/article/view/3166Histamine H1allergic conjunctivitisvasoconstrictorUFLC
spellingShingle Mahmood Ahmed
Amir Ali
Umar Farooq
Muhammad Makshoof Athar
Kashif Nadeem
Ghulam Murtaza
Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
Acta Chimica Slovenica
Histamine H1
allergic conjunctivitis
vasoconstrictor
UFLC
title Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
title_full Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
title_fullStr Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
title_full_unstemmed Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
title_short Stability indicating UFLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
title_sort stability indicating uflc pda assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations
topic Histamine H1
allergic conjunctivitis
vasoconstrictor
UFLC
url https://journals.matheo.si/index.php/ACSi/article/view/3166
work_keys_str_mv AT mahmoodahmed stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations
AT amirali stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations
AT umarfarooq stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations
AT muhammadmakshoofathar stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations
AT kashifnadeem stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations
AT ghulammurtaza stabilityindicatinguflcpdaassayforsimultaneousdeterminationofantazolinehydrochlorideandnaphazolinehydrochlorideinophthalmicformulations